相关实验视频
Updated: Jun 9, 2025
08:11
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Published on: August 14, 2016
30.8K
乳腺癌自发完全回归:两个病例报告
Orhan Yılmaz1, Ugur Kesici1, Mehmet Guray Duman1
1Department of General Surgery, Prof. Dr. Cemil Tascioglu City Hospital, University of Health Sciences, 34384 Istanbul, Türkiye.
Annali italiani di chirurgia
|October 28, 2024
概括
乳腺癌 (BC) 的自发回归 (SR) 是罕见的. 这项研究观察了两例SR的BC病例,没有发现PD-L1的支持.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 自发回归 (SR) 是瘤的不明原因消失,这是乳腺癌 (BC) 的罕见现象.
- 驱动SR的潜在机制在很大程度上仍未被阐明.
- 关于诸如编程死亡体1 (PD-L1) 等因素的现有假设需要进一步调查.
研究的目的:
- 研究乳腺癌自发回归的潜在机制.
- 分析经历SR的乳腺癌患者的临床和分子特征.
- 挑战关于SR的现有假设,特别是关于PD-L1的作用.
主要方法:
- 两名乳腺癌患者的案例研究显示自发回归.
- 在手术前进行临床检查和放射学评估.
- 对瘤标记物的分析,包括编程死亡体1 (PD-L1) 和Cerb B2状态.
主要成果:
- 两种观察到的乳腺癌病例均显示在没有治疗的情况下自发回归.
- 编程死亡连接体1 (PD-L1) 在两名患者中均呈阴性,这与其在SR中强有力的抗瘤活性理论相矛盾.
- 一名患者是首次报告的Cerb B2阳性乳腺癌与早期SR的病例,这表明SR机制的潜在21天时间表.
结论:
- 该研究提出了关于乳腺癌自发回归的初步发现,强调了需要精心进行手术前评估的必要性.
- 观察到的PD-L1负面性挑战了其在SR中所提议的作用,需要探索替代机制.
- 在Cerb B2阳性患者中早期SR的病例表明了潜在的快速时间表,并为对活组织的分子研究开辟了道路.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328